Get the Stockscreener App
7.885
1.42%
0.145
Shattuck Labs Inc stock is traded at $7.885, with a volume of 10,376.
It is up +1.42% in the last 24 hours and up +30.40% over the past month.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
See More
Previous Close:
$7.74
Open:
$7.9
24h Volume:
10,376
Relative Volume:
0.02
Market Cap:
$596.34M
Revenue:
$1,000.00K
Net Income/Loss:
$-48.81M
P/E Ratio:
-10.19
EPS:
-0.7737
Net Cash Flow:
$-39.95M
1W Performance:
-0.38%
1M Performance:
+30.40%
6M Performance:
+281.07%
1Y Performance:
+885.69%
1-Day Range:
$7.86
$7.93
1-Week Range:
$7.42
$8.13
52-Week Range:
$0.712
$8.33
Shattuck Labs Inc Stock (STTK) Company Profile
Name
Shattuck Labs Inc
Sector
Industry
Phone
512-900-4690
Address
500 W. 5TH STREET, AUSTIN
Compare STTK vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
7.89 | 585.00M | 1,000.00K | -48.81M | -39.95M | -0.7737 |
VRTX
Vertex Pharmaceuticals Inc
|
432.20 | 109.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
751.65 | 79.46B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
786.65 | 48.52B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
312.55 | 40.77B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
304.15 | 33.39B | 5.36B | 287.73M | 924.18M | 2.5229 |
Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Resumed | Needham | Buy |
| Jan-28-26 | Initiated | Piper Sandler | Overweight |
| Dec-01-25 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-08-25 | Initiated | Wedbush | Outperform |
| Mar-17-25 | Initiated | Leerink Partners | Outperform |
| Oct-02-24 | Downgrade | Citigroup | Buy → Neutral |
| Oct-02-24 | Downgrade | Needham | Buy → Hold |
| Oct-01-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-17-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-31-22 | Initiated | BTIG Research | Buy |
| Jun-01-22 | Initiated | Citigroup | Buy |
| May-02-22 | Initiated | H.C. Wainwright | Buy |
| Apr-14-21 | Initiated | Berenberg | Buy |
| Jan-11-21 | Initiated | Evercore ISI | Outperform |
| Nov-03-20 | Initiated | Citigroup | Buy |
| Nov-03-20 | Initiated | Cowen | Outperform |
| Nov-03-20 | Initiated | Needham | Buy |
View All
Shattuck Labs Inc Stock (STTK) Latest News
HC Wainwright Forecasts Stronger Earnings for Shattuck Labs - MarketBeat
Shattuck Labs (NASDAQ:STTK) Hits New 1-Year HighTime to Buy? - MarketBeat
H.C. Wainwright Maintains Shattuck Labs(STTK.US) With Buy Rating, Raises Target Price to $18 - Moomoo
Shattuck Labs (NASDAQ:STTK) Stock Price Up 6%What's Next? - MarketBeat
STTK Maintained by HC Wainwright & Co. -- Price Target Raised to $18 - GuruFocus
Shattuck Labs (STTK) Stock High Frequency (Skyrockets) 2026-04-20Stock Idea Sharing Hub - Cổng thông tin điện tử tỉnh Lào Cai
Shattuck Labs (STTK) Stock Pending Order (Tick Up) 2026-04-18Community Momentum Stocks - Cổng thông tin điện tử Tỉnh Sơn La
Needham Maintains Shattuck Labs(STTK.US) With Buy Rating, Maintains Target Price $14 - Moomoo
Street Watch: What is the cash position of Shattuck Labs IncStock Surge & Risk Controlled Daily Plans - baoquankhu1.vn
Piper Sandler Maintains Shattuck Labs(STTK.US) With Buy Rating, Maintains Target Price $15 - 富途牛牛
How expensive is Shattuck Labs (STTK) Stock now | Price at $6.97, Up 0.72%Breakout Stocks - Cổng thông tin điện tử tỉnh Tây Ninh
Shattuck Labs (STTK) price target increased by 37.93% to 10.20 - MSN
Aberdeen Group plc Buys 436,673 Shares of Shattuck Labs, Inc. $STTK - MarketBeat
Shattuck Labs Stock Surges 8.4% on Analyst Optimism - National Today
Shattuck Labs (NASDAQ:STTK) Trading Up 8.4%Here's Why - MarketBeat
Aug Retail: Is Shattuck Labs Inc stock suitable for long term investing2026 Technicals & Expert-Curated Trade Recommendations - baoquankhu1.vn
[ARS] Shattuck Labs, Inc. SEC Filing - Stock Titan
Shattuck Labs (NASDAQ: STTK) seeks approval of revamped equity plan at 2026 virtual meeting - Stock Titan
STTK Stock Price, Quote & Chart | SHATTUCK LABS INC (NASDAQ:STTK) - ChartMill
Shattuck Labs Announces Participation in Upcoming March Investor Conferences - 富途牛牛
Investor Mood: Is Shattuck Labs Inc a turnaround story2026 Final Week & High Conviction Investment Ideas - baoquankhu1.vn
STTK.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
STTK Should I Buy - Intellectia AI
STTK News & Events - Intellectia AI
Shattuck Labs, Inc. (NASDAQ:STTK) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
STTK.O Technical Analysis & Stock Price Forecast - Intellectia AI
Aug Catalysts: Is Shattuck Labs Inc a top pick in the sectorLong Setup & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Breakouts Watch: Is Shattuck Labs Inc stock a value trap2026 Retail & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
STTK PE Ratio & Valuation, Is STTK Overvalued - Intellectia AI
Shattuck Labs (NASDAQ:STTK) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Shattuck Labs: Surviving In An AI World Is Going To Be Tough (NASDAQ:STTK) - Seeking Alpha
Gap Down: Will Shattuck Labs Inc stock benefit from M AEarnings Growth Report & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Aug Wrap: Can Shattuck Labs Inc navigate macro headwinds2026 Trade Ideas & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Institution Moves: Is Shattuck Labs Inc a turnaround story2026 Bull vs Bear & Accurate Intraday Trading Signals - baoquankhu1.vn
MACD Signal: Will Shattuck Labs Inc benefit from green energy policies2026 Fundamental Recap & Target Return Focused Picks - baoquankhu1.vn
FOMO Trade: Is Shattuck Labs Inc stock a value trap2026 Levels & Weekly High Potential Stock Alerts - baoquankhu1.vn
Aug PostEarnings: What are the risks of holding Shattuck Labs Inc2026 Trading Recap & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Shattuck Labs (STTK) to Release Earnings on Thursday - MarketBeat
Profit Recap: What is the target price for Stardust Power Inc stockEarnings Summary Report & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Value Recap: Is The Hershey Company stock heavily shorted2026 PostEarnings & Weekly Breakout Watchlists - baoquankhu1.vn
STTK Technical Analysis & ETF Price Forecast - Intellectia AI
Short Interest in Shattuck Labs, Inc. (NASDAQ:STTK) Drops By 16.5% - MarketBeat
Shattuck Labs Receives $10 Price Target from Analysts - National Today
Prosight Management Trims Stake in Shattuck Labs - National Today
Analysts Have Conflicting Sentiments on These Healthcare Companies: Shattuck Labs (STTK), Oruka Therapeutics (ORKA) and Option Care Health (OPCH) - The Globe and Mail
Prosight Management LP Sells 1,187,740 Shares of Shattuck Labs, Inc. $STTK - MarketBeat
Shattuck Labs (STTK): Citigroup Raises Price Target to $7, Maint - GuruFocus
Citigroup Boosts Shattuck Labs (NASDAQ:STTK) Price Target to $7.00 - MarketBeat
Citi Increases Price Target for Shattuck Labs (STTK) with Potent - GuruFocus
Will Shattuck Labs Inc benefit from green energy policies2026 PreEarnings & Expert Approved Trade Ideas - baoquankhu1.vn
Shattuck Labs, Inc. (NASDAQ:STTK) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Shattuck Labs Inc Stock (STTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Shattuck Labs Inc Stock (STTK) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Ashiya Mona | Director |
Aug 25 '25 |
Buy |
0.87 |
6,306,127 |
5,471,826 |
5,255,106 |
0.03%
0.66%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):